1. Research transparency strategy
Andrew George, NED
Juliet Tizzard, Director of Policy
HRA Board | 15 May 2019

2. Strategy group

3. Vision and scope Vision
Patients, the public and professionals can easily access useful information about health and care research studies
Scope
Although the scope of this strategy extends to all health and care research which involves people, their tissue or their personal data, our initial focus is on clinical trials. These are research studies which test the safety and effectiveness of new patient interventions such as medicines, medical devices, surgical techniques, public health measures and behavioural therapies

4. Areas for consultation
General feedback on the vision, scope and HRA’s mission and commitments
Views about:
measures to increase clinical trials registration
measures to increase feedback to participants
measures to increase reporting of results
considering track record when considering new studies for approval

5. Strategy timeline June: start consultation April/May June July August
Sept/Oct
November
Draft strategy developed
Open online survey
Workshops: researchers and patients
Workshops: HRA staff and ethics committees
Analyse feedback from consultation
HRA Board agrees strategy
Ongoing engagement with key stakeholders
Early Sept: end consultation

6. Ongoing engagement Outside of the strategy group, we are talking to:
Campaigners
Registries
Academy of Medical Sciences
DHSC
NHS R&D community
Science and Technology Committee

7. Communications We’re making plans for how to launch the strategy by:
Using the media (including medical) to extend the reach of the consultation
Working with partner organisations to extend the reach of the consultation
Developing a brand identity for our work

8. Thank you Follow us on Twitter @HRA_Latest
Sign up for our monthly newsletter at